(VPH: CSE) (VPHIF: OTCQB) (VP2: FSE)
Why Valeo Pharma?
Draganfly to Showcase its Health Security and Telehealth Technologies
Los Angeles, CA, Jan. 07, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce that it will be attending this year’s Consumer and Electronics Show taking place virtually January 11-14, 2021.
Draganfly will be featuring its Vital Intelligence system which can enable existing camera systems or cameras on kiosks, drones, tables and smartphones to measure vital signs as well as its Varigard 24hr pathogen sequestration and kill sanitizing spray applied via patented drone.
“We are very proud to be bringing Draganfly to CES this year,” said Cameron Chell, CEO of Draganfly. “CES is rooted in technology innovation. Draganfly is excited to showcase our innovations which we rolled out through the National Safely Opening Site and National Safely Opening Schools COVID-19 safety protocol. This included the development of our Vital Intelligence health-tech, our drone vaccination delivery and our 24-hour sequestration sanitizer delivered to stadiums, arenas, malls and conference centers delivered by drone.”
Draganfly will provide a live demo of its Vital Intelligence technology on January 13, 2021 at 130PM PST/430PM EST. Click here to register.
VANCOUVER, BC and ERIE, Pa. , Jan. 7, 2021 – Imagine AR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that enables sports teams, businesses, and organizations to create instant AR engagement and activation global campaigns without a technical background, is pleased to announce it is one of six global companies featured in the GSIC White Paper augmented reality fan engagement case study to be published and formally presented on January 19, 2021 . ImagineAR CEO Alen Paul Silverrstieen will be a panelist on the global webcast presentation.
The “Next-Generation Fan Engagement: The Coming Together of Content, Commercial, Code & The Consumer” by GSIC (powered by Microsoft), white paper is divided into two parts – the first half details how the historical business model of Sport is gradually eroding due to the fragmentation of audiences due to the proliferation of smart phones and 4G data connectivity. The second half details innovative fan engagement solutions that deliver commercial and strategic benefits by using next- generation technologies such as augmented reality, computer vision & blockchain.
The ImagineAR case study features the Louisville Bats baseball team, Cincinnati Reds Triple-A Affiliate, Restaurant Augmented Reality Mascot Partnership Program from early 2020. Click to learn more .
ImagineAR CEO, Alen Paul Silverrstieen said “The GSIC, powered by Microsoft, is a highly respected global organization consulting with many of the leading sports organizations and teams. We are honored to be included as a mobile augmented reality case study in this new white paper. It will further enhance our status as a leader in sports fan engagement using AR and create new global sales opportunities.”
When a small cap company enters into a developer and supply agreement with a technology leader in its space AND can’t name the company, that is typically a very good thing.
Understanding the world of Photonics isn’t the easiest thing small cap investors have had to understand. In fact, it may be the very hardest thing they’ve ever had to understand. However, given the fact we are the very reason current photonics devices aren’t living up to snuff trying to keep up with our surfing, streaming, binging and zooming – you start to see why understanding photonics and POET Technologies could open up investors to a whole new world.
We went beyond the press release with POET management to discuss its “Entry Into Artificial Intelligence Market With Undisclosed Leader In Photonic Computing” No, we didn’t understand the title at first either ….. but the management trio on the Zoom did a great job explaining it in terms that are both compelling yet understandable.
Before watching this video, here is some important background information.
Photonic devices create, detect and manipulate light. Laser generated light is fundamental to sensing, computing, data and telecommunications, which require the fastest transfer of data possible.
This is where POET comes in.
Why? All the surfing, streaming, binging and zooming we do requires 2 things to happen:
1. Massive data centres filled with tens of thousands of servers.
2. Speed … and we mean lighting speed that requires lasers to transfer all that data fast enough for you not to complain about 2 second latency when searching for weight-loss programs for your New Year’s resolution (We see you).
Examples of the the biggest trends sucking up all that power and speed in computing today:
HERE IS THE PROBLEM
Making photonics devices that are reliable is expensive in terms of both capital and labor. Unlike almost every electronic device or component on this planet that has seen their costs drop dramatically over time, photonics cost declines have not kept up with Moore’s Law, with most photonics devices built one at a time. (NOT A TYPO).
The Result? Integration of components at wafer-scale has not been fully implemented even by the largest companies working for the past 20 years ….. UNTIL NOW
POET has developed a unique, disruptive and differentiating new entry into photonics markets – The POET Optical Interposer™ Platform. Don’t worry if that sounds like a mouthful. All you have to know is that it
Today’s press release announcing its entry into the “Artificial Intelligence Market with Technology Leader in Photonic Computing” serves as great 3rd party validation that POET Technologies can open up the AI market for its Optical Interposer Platform.
Watch this great interview with:
Los Angeles, CA, Jan. 06, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce the awarding of a new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.
The design is ideal for Beyond Visual Line of Sight (BVLOS) and for transporting goods in hard to reach areas or flight over people at night.
US Patent No. 10,807,707 is an unmanned aircraft system (UAS) configured for both vertical take-off and landing (VTOL) and fixed-wing flight operations includes forward, and aft wing assemblies mounted to the fuselage, each wing assembly including port and starboard nacelles terminating in motor-driven rotors powered by an onboard control system capable of adjusting rotor speeds.
TORONTO, Jan. 06, 2021 — POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today announced that it has entered into development and supply agreements with a technology leader in photonic neural network systems for Artificial Intelligence (AI) applications.
Artificial Intelligence, at the cusp of its own revolutionary impact to humanity, is driving an unprecedented demand for computation at the same time that the physics of digital semiconductors, driven by Moore’s law, is reaching its end. Transistor scaling is approaching its limits and AI accelerator companies are struggling to keep pace with demands, particularly in “edge” applications that require greater power and cost efficiency. Domain-specific architectures targeted to AI workloads can make up for some of the slowdown in transistor advances but that approach also has its limits.
TORONTO, Jan. 05, 2021 — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce two investments, for a total of $530,000 in Electric Metals (USA) Ltd. (“EML ”), a multi-commodity US-based resource company focused on their 100% owned Corcoran Canyon Silver Project in Nevada and Emily Manganese Project in Minnesota.
In the first private placement, The Company has acquired 1,000,000 shares (the “Shares”) at a price of $0.20 per Share in EML.
In the second private placement, The Company has acquired 1,000,000 Subscription Receipts (the “Sub Receipts”) at a price of $0.33 per Sub Receipts. Each Sub Receipts will entitle ThreeD to receive one (1) common share of EML (a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”), with each whole warrant exercisable at $0.60 per Warrant. The Warrants will expire two (2) years from the date of issuance.
EML signed a definitive scheme implementation agreement, effective 31st December 2020, with NBS Capital Inc. (“NBS”) (TSXV: NBS.P), as announced yesterday by NBS. Pursuant to this Agreement, NBS will acquire all of the shares of EML via share exchange for an equivalent number of NBS shares, which will result in EML becoming a wholly owned subsidiary of NBS. NBS will change its name change to Nevada Silver Corporation on closing of the proposed transaction, reflecting the focus of EML on its principal Nevada silver asset.
Sheldon Inwentash has also agreed to come on as Chairman of the Board of Directors to NBS, which will take effect upon the closing of the proposed transaction with NBS.
Sheldon Inwentash, Chairman and CEO of ThreeD Capital stated “ThreeD Capital prides itself on discovering great companies before they become known to the general investment community, and EML is no exception. With 100% ownership of a US-based primary silver-gold asset with existing resources and significant upside potential, I am confident EML will deliver exceptional value to IDK shareholders.”
Gary Lewis, Director and CEO of EML commented, “We are delighted to welcome ThreeD Capital onto the EML register and Mr. Sheldon Inwentash as our incoming Chairman at such a pivotal time in the company’s development. EML has built a strong asset base and technical capability which, when coupled with the reputation, rolodex and investment nous of Mr. Inwentash, will make for a very compelling combination.”
This Press Release is available on the ThreeD Capital verified forum on AGORACOM. The forum is live and can be found at https://agoracom.com/ir/threedcapital/forums/discussion
About Electric Metals (USA) Ltd.
EML is an unlisted public company incorporated under the laws of New South Wales, Australia. It is a U.S.-based resource company, with its material asset being the 100-per-cent-owned Corcoran Canyon silver project in Nevada. EML also holds a high-grade manganese project in Minnesota, United States.
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.
For further information:
Gerry Feldman, CPA, CA
Chief Financial Officer and Corporate Secretary
[email protected]
Phone: 416-941-8900 ext 106
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Forward-Looking Statements
This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws including, without limitation, statements with respect to the future investments by the Company. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.
(VPH: CSE) (VPHIF: OTCQB) (VP2: FSE)
Why Valeo Pharma?
What Exactly Does Valeo Pharma Do?
Watch Our Recent Interview:
Hub On AGORACOM / Corporate Profile
FULL DISCLOSURE: Valeo Pharma is an advertising client of AGORA Internet Relations Corp.
Famed Canadian Investor Sheldon Inwentash Founder, Chairman and CEO ThreeD Capital praises Loop Insights. Inwentash is extremely impressed with the company’s technology and goes on to say that Loop Insights CEO Rob Anson is the hardest working small cap CEO he knows.
ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce a US$450,000 investment in Wuhan General Group (China) Inc. (OTC PINK:WUHN) (“Wuhan”), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research.
The Company will acquire 1,500,000 units (the “Units”) at a price of US$0.30 per Unit. Each Unit will consist of one (1) common share of Wuhan (a “Common Share”) and one Common Share purchase warrant (a “Warrant”) exercisable at US$0.30 per Warrant. The Warrants will expire three (3) years from the date of issuance. The closing date for the private placement will be at the latest on January 31, 2021.
Sheldon Inwentash, Chairman and CEO of ThreeD Capital stated, “The investment thesis of ThreeD Capital is that psychedelics are going to experience a paradigm shifting and parabolic growth stage over this decade, leading to a critical role in the treatment of anxiety, depression, addiction and other mental health issues that traditional pharmaceuticals have not been able to adequately solve. Though we have made other smaller investments in the space, our investment in Wuhan General Group (China) represents our largest investment to date in a psychedelics company. We are investing in Wuhan General Group (China) because of the deep expertise and scientific knowledge this company has in psychedelics.”
This Press Release is available on the ThreeD Capital verified forum on AGORACOM. The forum is live and can be found at https://agoracom.com/ir/threedcapital/forums/discussion
About Wuhan General Group (China) Inc.
Wuhan General Group (China) Inc., through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™ and Handcrafted Delights™ brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research and emerging technologies. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol “WUHN”.
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.
| For further information: |
| Gerry Feldman, CPA, CA |
| Chief Financial Officer and Corporate Secretary [email protected] |
| Phone: 416-941-8900 ext 106 |